Mithra Pharmaceuticals Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Christophe Marechal
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 7.2yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 4yrs |
| Promedio de permanencia en la Junta Directiva | 2.3yrs |
Actualizaciones recientes de la dirección
Recent updates
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%
Apr 06
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive
Feb 07Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts
Nov 09These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts
Oct 05Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
May 23Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts
Aug 11Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%
Mar 13Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt
Dec 22Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 24Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt
Jun 07When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?
May 10Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?
Mar 18We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings
Feb 16Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long
Jan 21
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 29CEO
Christophe Marechal
7.2yrs
Permanencia
Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-CEO & CFO | 7.2yrs | sin datos | sin datos | |
| COO & Co-CEO | less than a year | sin datos | sin datos | |
| Chief Scientific Officer | 4.8yrs | sin datos | sin datos | |
| Head of Investor Relations | no data | sin datos | sin datos | |
| Secretary of the Board & General Counsel | no data | sin datos | sin datos | |
| Compliance Officer | no data | sin datos | sin datos | |
| Communication Director | no data | sin datos | sin datos | |
| HR Director | no data | sin datos | sin datos | |
| Chief Commercial & External Affairs Officer | 3.3yrs | sin datos | 0.000040% € 6.4 | |
| President of the Scientific Advisory Board & Executive Director | no data | €7.12k | 0.029% € 4.7k | |
| Head of Global Regulatory Affairs | no data | sin datos | sin datos | |
| Head of Program & Project Management | no data | sin datos | sin datos |
4.0yrs
Permanencia media
Equipo directivo experimentado: MITRAEl equipo directivo de la empresa se considera experimentado (3.1 años de antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President of the Scientific Advisory Board & Executive Director | 7.6yrs | €7.12k | 0.029% € 4.7k | |
| Independent & Non-Executive Director | 1.3yrs | €25.00k | sin datos | |
| Non-Executive Director | 2.3yrs | €20.00k | 0.042% € 6.8k |
2.3yrs
Permanencia media
Junta con experiencia: La junta directiva de MITRA no se considera experimentada (2.2 años de permanencia promedio), lo que sugiere una nueva junta directiva.